PTO/SB/SS (04-09)
`Approved for use through 05/31/2009. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`
`
`Applicant/Patent Owner Pfizer Inc and Pfzer Products Inc“
`
`STATEMENT UNDER 37 CFR 3.73tb)
`
`FIIed/Issue Date: September 4 2007
`
`Tltledi
`
`TARTRATE SALTS OF 5,8, 14-TRIAZATERACYCLO[10.3.1.02,11 04.9]—HEXADECA—2(11),3,5,7,9-PENTAEN
`AND PHARMACEUTICAL COMPOSITIONS THEREOF
`
`Pfizer Inc. and Pfizer Products Inc.
`(Name of Assignee)
`
`. a
`
`Corporation
`(Type of Assignee. e.g., corporation, partnership, university, government agency. etc.
`
`states that it is:
`
`1.
`
`the assignee of the entire right, title, and interest in;
`
`an assignee of less than the entire right, title, and interest in
`(The extent (by percentage) of its ownership interest is
`
`%); or
`
`the assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`
`the patent application/patent identified above, by virtue of either:
`
`A. D An assignment from the inventor(s) of the patent application/patent identified above. The assignment was recorded in
`the United States Patent and Trademark Office at Reel
`, Frame
`, or for which a
`copy therefore is attached.
`
`OR
`
`B.
`
`A chain of title from the inventor(s), of the patent application/patent identified above, to the current assignee as follows:
`
`1. From:
`
`see attached
`
`To:
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`or for which a copy thereof is attached.
`
`2. From:
`
`3. From:
`
`To:
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Real
`
`,
`
`Frame
`
`,
`
`or for which a copy thereof is attached.
`
`To:
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`or for which a copy thereof is attached.
`
`[:1
`
`Additional documents in the chain of title are listed on a supplemental sheet(s).
`
`D As required by 37 CFR 3.73(b)(1)(i), the documentary evidence of the chain of title from the original owner to the assignee was,
`or concurrently is being, submitted for recordatlon pursuant to 37 CFR 3.11.
`
`[NOTE: A separate copy (i. e, a true copy of the original assignment document(s)) must be submitted to Assignment Division in
`accordangeffwith 37 CFR Part 3, to record the assignment in the records of the USPTO. S_ee MPEP 302.08]
`The underargnedfivfigae titleIs supplied below)Is authorized to act on behalf of the assignee
`
` Application No./Patent No.:7265.119
`
`January 11, 2010
`Date
`
`VP and Assis. GC (Pfizer Inc.)
`Vice President (PPI)
`Title
`
`This collection of information'Is required by 37 CFR 3.73(b). The information"Is required to obtain or retain a benefit by the public whichIs to file (and by the USPTO to
`process) an application. Confidentiality'Is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collectionIs estimated to take 12 minutes to complete, including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time
`you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.8. Patent and Trademark Office, U.S.
`Department of Commerce. P.O Box 1450, Alexandria VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner
`for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance In completlng the form, call 1-800-PTO-9199 and select option 2.
`
`